Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Zheng-Zhen Chen"'
Autor:
Xiu-Lan Sun, Ji-Ye Huang, Lulu Cao, Ruo-Bing Guo, Juan Ji, Yin-Feng Dong, Ling Zhang, Jun Lu, Zheng-Zhen Chen, Jin Wu
Publikováno v:
Journal of Cellular and Molecular Medicine
Fingolimod (FTY720) is used as an immunosuppressant for multiple sclerosis. Numerous studies indicated its neuroprotective effects in stroke. However, the mechanism remains to be elucidated. This study was intended to investigate the mechanisms of ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24403dad706be36fdf641c54b138a0f7
https://doi.org/10.1111/jcmm.13596
https://doi.org/10.1111/jcmm.13596
Autor:
Yin-Feng Dong1,2, Zheng-Zhen Chen1, Zhan Zhao1, Dan-Dan Yang1, Hui Yan1, Juan Ji1, Xiu-Lan Sun1 xiulans@njmu.edu.cn, Dong, Yin-Feng2,3 (AUTHOR), Chen, Zheng-Zhen3 (AUTHOR), Zhao, Zhan3 (AUTHOR), Yang, Dan-Dan3 (AUTHOR), Yan, Hui3 (AUTHOR), Ji, Juan3 (AUTHOR), Sun, Xiu-Lan3 (AUTHOR)
Publikováno v:
Journal of Neuroinflammation. 3/9/2016, Vol. 13, p1-10. 10p.
Publikováno v:
Journal of Neuroinflammation
Background It is generally recognized that the inflammatory reaction in glia is one of the important pathological factors in brain ischemic injury. Our previous study has revealed that opening ATP-sensitive potassium (K-ATP) channels could attenuate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87ff2e3d84ca7b76a394f4a23dac0f10
https://doi.org/10.1186/s12974-016-0527-5
https://doi.org/10.1186/s12974-016-0527-5
Publikováno v:
Life sciences. 150
Aims Memantine is a low-moderate affinity and uncompetitive N-methyl- d -aspartate receptor (NMDAR) antagonist, which is also a potential neuroprotectant in acute ischemic stroke for its particular action profiles. The present study was to reveal the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abff963b13ed17118ea210ec203ca86c
https://pubmed.ncbi.nlm.nih.gov/26920629
https://pubmed.ncbi.nlm.nih.gov/26920629
Publikováno v:
Clinical and experimental pharmacologyphysiology. 42(7)
It has been reported that the novel ATP-sensitive potassium (K-ATP) channel opener iptakalim (IPT) decreases ischemic neuronal damage in rats. However, the mechanisms underlying neuroprotection are still to be fully elucidated. The results of this st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dd6e149c6c184fd9a38885900cb2f66
https://pubmed.ncbi.nlm.nih.gov/25998857
https://pubmed.ncbi.nlm.nih.gov/25998857